Documente Academic
Documente Profesional
Documente Cultură
Andreas Seiger
Director Diabetes Marketing & Market Access Novo Nordisk Canada Inc.
Slide no 2
Pharmaceutical and biopharmaceutical companies are under severe pressure to improve product pipelines, accelerate time to market, and improve margins on existing products - while also maintaining strict adherence to quality principles and regulatory requirements. However, drug development is a long process with significant risks, and pharmaceutical companies are faced with intense competitive pressures and patent expirations that threaten profitability.
Slide no 3
5,000 10,000
200 - 300
5 - 10
1-3
Slide no 4
Launch
NovoMix 30
Victoza
Optimize
2008
2009
2010
Retire
Mix 10/20
Slide no 5
Slide no 6
Forecasting tools
Environment assessment (Health Care system, Demographics, Competition etc) 2-3 different statistical techniques (sensitivity analyses) Benchmarking with comparable products Expert advise
Risk assessment
Slide no 7